- Home
- RPRX vs MDB Comparison
RPRX vs MDB Comparison
Compare RPRX & MDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- MDB
- Stock Information
- Founded
- RPRX 1996
- MDB 2007
- Country
- RPRX United States
- MDB United States
- Employees
- RPRX N/A
- MDB N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- MDB Computer Software: Prepackaged Software
- Sector
- RPRX Health Care
- MDB Technology
- Exchange
- RPRX Nasdaq
- MDB Nasdaq
- Market Cap
- RPRX 16.2B
- MDB 15.8B
- IPO Year
- RPRX 2020
- MDB 2017
- Fundamental
- Price
- RPRX $39.06
- MDB $374.62
- Analyst Decision
- RPRX Strong Buy
- MDB Strong Buy
- Analyst Count
- RPRX 3
- MDB 36
- Target Price
- RPRX $46.00
- MDB $356.44
- AVG Volume (30 Days)
- RPRX 3.5M
- MDB 1.6M
- Earning Date
- RPRX 11-05-2025
- MDB 12-01-2025
- Dividend Yield
- RPRX 2.26%
- MDB N/A
- EPS Growth
- RPRX N/A
- MDB N/A
- EPS
- RPRX 1.75
- MDB N/A
- Revenue
- RPRX $2,349,844,000.00
- MDB $2,218,189,000.00
- Revenue This Year
- RPRX $36.16
- MDB $18.67
- Revenue Next Year
- RPRX $2.04
- MDB $17.01
- P/E Ratio
- RPRX $22.24
- MDB N/A
- Revenue Growth
- RPRX 3.70
- MDB 21.91
- 52 Week Low
- RPRX $24.05
- MDB $140.78
- 52 Week High
- RPRX $41.24
- MDB $385.44
- Technical
- Relative Strength Index (RSI)
- RPRX 59.55
- MDB 70.05
- Support Level
- RPRX $38.39
- MDB $339.00
- Resistance Level
- RPRX $41.24
- MDB $377.84
- Average True Range (ATR)
- RPRX 1.18
- MDB 14.77
- MACD
- RPRX 0.17
- MDB 2.23
- Stochastic Oscillator
- RPRX 59.15
- MDB 82.01
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About MDB MongoDB Inc.
Founded in 2007, MongoDB is a vendor of a document-oriented database that accelerates development processes of new applications. Enterprise customers can choose between the fully managed offering, MongoDB Atlas, or the self-managed version, MongoDB Enterprise Advanced. MongoDB is a popular tool among developers, and its free Community Server has recorded over 500 million downloads since 2009.